Cervical Health

The annual percentage changes of cervical cancer incidence and mortality in Appalachian Kentucky from 2009 to 2019 were 2.9% and 4.5% respectively.

In a recent study, overall and cervical-cancer specific deaths were more common among cervical cancer patients with a preexisting mental health disorder.

In a recent study, patients with early-stage cervical cancer receiving radical hysterectomy had increased survivability.

The effects of GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) in patients aged 9 to 15 years has indicated efficacy, according to a recent long-term follow-up study.

In a recent study, the prediction values of cervical cancer prediction models increased significantly when human papillomavirus genotypes were included in the evaluation.

In a recent study, women with preterm prelabor rupture of membranes had higher rates of intraamniotic infection when a history of cervical excisional treatment was reported.

Jonathan Miller, MD, pediatrician and chief of primary care, pediatrics at Nemours Children’s Health in the Delaware Valley, spoke about the latest data regarding early human papillomavirus (HPV) vaccination in children as young as 9 years old at the 2023 Pediatric Academic Societies meeting. He also provided some clinical pearls for opening the conversation with patients’ caretakers regarding earlier HPV vaccination.

In a recent study, the risk of cervical intraepithelial neoplasia recurrence was reduced in patients using imiquimod.

In a recent study, pregnancies with preterm prelabor rupture of membranes were associated with greater risks of intraamniotic infection, microbial invasion of the amniotic cavity without inflammation, and early-onset neonatal sepsis development in women with a history of cervical excisional treatment.

Jeff Andrews, MD, FRCSC, Vice President of Medical Affairs for Integrated Diagnostic Solutions at BD, discusses the link between human papillomavirus (HPV) and cervical cancer, and how HPV self-sampling kits may increase rates of cervical cancer screening.

Anne Banfield, MD, discusses the highlights from her presentation on primary HPV screening at the 2023 ACOG Annual Clinical and Scientific Meeting in Baltimore, Maryland.

In a recent study, under-screened patients were more likely to receive cervical cancer screening after receiving at-home high-risk human papillomavirus sampling kits.

When examining studies on cervical cerclage placement and complications, reviewers found complications were most common in physical examination-indicated cerclage and least common in history-indicated cerclage.

In a recent study, patients receiving interventions designed to increase adherence to screenings for breast, cervical, or colorectal cancers were more likely to be up to date on any or all screenings.

January is Cervical Cancer Awareness Month. Check out the most up-to-date statistics on HPV and cervical cancer.

This month is a perfect opportunity for ob-gyns and other women’s health care providers to raise awareness about cervical cancer and HPV vaccination.

Although human papillomavirus testing with urine is slightly less sensitive than using cervical samples, it may be easier for women than going to a doctor’s office for a Pap smear.